TCF7 anticorps (N-Term)
Aperçu rapide pour TCF7 anticorps (N-Term) (ABIN357291)
Antigène
Voir toutes TCF7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- This antibody detects TCF7 at N-term.
-
Purification
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
-
Immunogène
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human TCF7.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
-
ELISA 1: 1,000. Western blot 1: 100 - 1: 500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- TCF7 (Transcription Factor 7 (T-Cell Specific, HMG-Box) (TCF7))
-
Autre désignation
- TCF7 / TCF1
-
Sujet
- The T cell specific transcription factor TCF7 activates genes involved in immune regulation and thymocyte differentiation, and is a candidate locus for genetic susceptibility to type 1 diabetes.Synonyms: T-cell factor 1, T-cell-specific transcription factor 1, TCF-1, TCF-7, Transcription factor 7
-
Poids moléculaire
- 41552 Da
-
ID gène
- 6932
-
NCBI Accession
- NP_001128323
-
UniProt
- P36402
-
Pathways
- Signalisation WNT
Antigène
-